3T Biosciences - Crunchbase Company Profile & Funding

Q: Who invested in 3T Biosciences?

3T Biosciences has 10 investors including Lightspeed Venture Partners And Westlake Village BioPartners.

Q: When was the last funding round for 3T Biosciences?

3T Biosciences closed its last funding round on obfuscated from a Series A round.

Q: How much funding has 3T Biosciences raised to date?

3T Biosciences has raised obfuscated.

Overview

3T Biosciences

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About 3T Biosciences

CB Rank

9555

3T Biosciences is an immunotherapy company that develops next-generation therapies for cancer and immune-mediated diseases.

Founded

obfuscation

Private

Series A

Menlo Park, California, United States

11-50

www.3tbiosciences.com

Biopharma

Biotechnology

Health Care

Funding Rounds

Series A

OBF

obfuscation

Seed

OBF

obfuscation

Convertible Note

OBF

obfuscation

Key People

Stefan Scherer: CEO and President
Past Role: Novartis, Vice President, Head Early Development, Strategy and Innovation
Marvin Gee: Co-Founder, Head of Target Discovery

Details

Legal Name

BIOSCIENCES, INC.

Operating Status

Active

Company Type

For Profit

Founders

Leah Sibener, Marvin Gee

About the Company

Founded in 2017, 3T Biosciences is an immunotherapy company headquartered in Menlo Park, California.

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Insight

See this Growth Insight

3T Biosciences is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

3T-TRACE Platform

A discovery platform that identifies novel T-cell receptor targets and screens for specificity and cross-reactivity to develop targeted immunotherapies.

TCRm Bispecifics

Therapeutic molecules that target known and novel T-cell receptor targets to engage immune responses against cancer cells.

Research & Development

3T Biosciences is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - 3T Biosciences	2	obfuscated obfuscation	Lightspeed Venture Partners, Westlake Village BioPartners	Series A
obfuscated obfuscation	Series A - 3T Biosciences	2	obfuscated obfuscation	Lightspeed Venture Partners, Westlake Village BioPartners	Series A
obfuscated obfuscation	Series A - 3T Biosciences	2	obfuscated obfuscation	Lightspeed Venture Partners, Westlake Village BioPartners	Series A
obfuscated obfuscation	Series A - 3T Biosciences	2	obfuscated obfuscation	Lightspeed Venture Partners, Westlake Village BioPartners	Series A
obfuscated obfuscation	Series A - 3T Biosciences	2	obfuscated obfuscation	Lightspeed Venture Partners, Westlake Village BioPartners	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - 3T Biosciences	2	obfuscated obfuscation	Lightspeed Venture Partners, Westlake Village BioPartners	Series A
obfuscated obfuscation	Series A - 3T Biosciences	2	obfuscated obfuscation	Lightspeed Venture Partners, Westlake Village BioPartners	Series A
obfuscated obfuscation	Series A - 3T Biosciences	2	obfuscated obfuscation	Lightspeed Venture Partners, Westlake Village BioPartners	Series A
obfuscated obfuscation	Series A - 3T Biosciences	2	obfuscated obfuscation	Lightspeed Venture Partners, Westlake Village BioPartners	Series A
obfuscated obfuscation	Series A - 3T Biosciences	2	obfuscated obfuscation	Lightspeed Venture Partners, Westlake Village BioPartners	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Lightspeed Venture Partners	Yes	Series A - 3T Biosciences	Shelley Chu
Lightspeed Venture Partners	Yes	Series A - 3T Biosciences	Shelley Chu
Lightspeed Venture Partners	Yes	Series A - 3T Biosciences	Shelley Chu
Lightspeed Venture Partners	Yes	Series A - 3T Biosciences	Shelley Chu
Lightspeed Venture Partners	Yes	Series A - 3T Biosciences	Shelley Chu